• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
LeadershipMartin Shkreli

Letter from Martin Shkreli: “I Hope To See You and Your Four Children Homeless”

By
Chris Morris
Chris Morris
Former Contributing Writer
By
Chris Morris
Chris Morris
Former Contributing Writer
July 19, 2017, 9:47 AM ET

The trial of “pharma bro” Martin Shkreli gets weirder and weirder.

Tim Pierotti, who once ran a consumer hedge fund for Shkreli, testified Tuesday that the man who gained notoriety by raising the price of a life-saving drug more than 5,000% sent a threatening letter to his home, addressed to his wife, reading, “I hope to see you and your four children homeless. I will do whatever I can to assure this.”

The letter was entered into evidence at Shkreli’s trial in Federal District Court in Brooklyn.

In the letter, Shkreli accused Pierotti of stealing $1.6 million from him and added, “making an enemy out of me is a mistake.” The theft accusation allegedly revolved around the sale of shares of Retrophin, a biopharmaceutical company Shkreli ran.

The two men met in 2011, when Pierotti joined MSMB, Shkreli’s hedge fund. Pierotti testified that he put all of the money from that fund into one stock—Rick’s Cabaret, a chain of strip clubs, with Shkreli’s approval.

It’s the latest in a long series of odd moves for Shkreli, who also paid $2 million for the sole copy of a Wu-Tang Clan album (something he might have to forfeit should the trial not go his way).

If nothing else, it sounds like the Off-Broadway musical based on his life might have to be expanded.

About the Author
By Chris MorrisFormer Contributing Writer

Chris Morris is a former contributing writer at Fortune, covering everything from general business news to the video game and theme park industries.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.